Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 21, 2023

SELL
$10.88 - $20.05 $7.83 Million - $14.4 Million
-719,373 Reduced 44.9%
882,664 $10.1 Million
Q3 2022

Nov 14, 2022

SELL
$16.06 - $26.39 $5.51 Million - $9.05 Million
-342,981 Reduced 17.63%
1,602,037 $27.3 Million
Q2 2022

Aug 15, 2022

BUY
$20.49 - $39.72 $4.86 Million - $9.43 Million
237,381 Added 13.9%
1,945,018 $41.8 Million
Q1 2022

May 16, 2022

BUY
$28.19 - $46.6 $2.36 Million - $3.89 Million
83,575 Added 5.15%
1,707,637 $63.2 Million
Q4 2021

Feb 11, 2022

SELL
$41.2 - $73.6 $507,419 - $906,457
-12,316 Reduced 0.75%
1,624,062 $73.9 Million
Q3 2021

Nov 12, 2021

BUY
$59.15 - $91.99 $11.4 Million - $17.8 Million
193,535 Added 13.41%
1,636,378 $104 Million
Q2 2021

Aug 13, 2021

BUY
$63.02 - $95.11 $90.8 Million - $137 Million
1,440,526 Added 62172.03%
1,442,843 $132 Million
Q1 2021

May 14, 2021

BUY
$57.62 - $95.6 $4,033 - $6,692
70 Added 3.12%
2,317 $158,000
Q4 2020

Feb 16, 2021

BUY
$41.43 - $77.09 $38,115 - $70,922
920 Added 69.33%
2,247 $162,000
Q2 2020

Aug 11, 2020

BUY
$18.95 - $35.43 $25,146 - $47,015
1,327 New
1,327 $47,000
Q1 2020

May 15, 2020

SELL
$13.94 - $28.25 $910,602 - $1.85 Million
-65,323 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$19.24 - $28.41 $253,698 - $374,614
-13,186 Reduced 16.8%
65,323 $1.41 Million
Q3 2019

Nov 14, 2019

BUY
$20.03 - $40.08 $736,683 - $1.47 Million
36,779 Added 88.14%
78,509 $1.78 Million
Q2 2019

Aug 14, 2019

SELL
$25.78 - $39.77 $88,012 - $135,774
-3,414 Reduced 7.56%
41,730 $1.5 Million
Q1 2019

May 15, 2019

SELL
$22.09 - $39.21 $107,070 - $190,050
-4,847 Reduced 9.7%
45,144 $1.42 Million
Q4 2018

Feb 15, 2019

SELL
$19.89 - $30.02 $13,923 - $21,014
-700 Reduced 1.38%
49,991 $1.26 Million
Q3 2018

Nov 15, 2018

BUY
$12.1 - $28.85 $355,631 - $847,930
29,391 Added 137.99%
50,691 $1.46 Million
Q2 2018

Aug 14, 2018

SELL
$7.93 - $15.79 $457,561 - $911,083
-57,700 Reduced 73.04%
21,300 $261,000
Q1 2018

May 11, 2018

BUY
$5.18 - $7.97 $275,058 - $423,207
53,100 Added 205.02%
79,000 $630,000
Q4 2017

Feb 15, 2018

BUY
$3.98 - $7.37 $103,082 - $190,883
25,900
25,900 $190,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.